moxifloxacin has been researched along with dicyclomine in 2 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (dicyclomine) | Trials (dicyclomine) | Recent Studies (post-2010) (dicyclomine) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 398 | 41 | 74 |
| Protein | Taxonomy | moxifloxacin (IC50) | dicyclomine (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.468 | |
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.046 | |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.0029 | |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 0.0024 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.0035 | |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 0.0044 | |
| Histamine H2 receptor | Homo sapiens (human) | 1.625 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.24 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.468 | |
| D(3) dopamine receptor | Homo sapiens (human) | 1.21 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 1.301 | |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 3.065 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.0049 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for moxifloxacin and dicyclomine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for moxifloxacin and dicyclomine
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |